恶心,吐和非血性腹在急诊室
Nate Albright1, Stephen McGhee1, Dianne Morrison-Beedy1
1College of Nursing, The Ohio State University, Columbus, OH.
The journal for nurse practitioners : JNP
|March 18, 2024
概括
在开始预防艾滋病毒的口服暴露前预防 (PrEP) 时,胃肠道不适是常见的. 识别这种"启动综合征"有助于临床医生准确诊断和管理出现恶心,吐或腹的患者.
科学领域:
- 临床医学 临床医学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 恶心,吐和腹是常见的症状,可以模糊诊断.
- "结束艾滋病毒流行"倡议促进预防艾滋病毒的暴露前预防 (PrEP).
- 口服PrEP配方可能会引起胃肠道 (GI) 障碍,称为"启动综合征".
研究的目的:
- 强调在临床管理中考虑与PrEP相关的胃肠道症状的重要性.
- 强调性健康史在诊断PREP患者中的作用.
- 改善临床医生对PrEP"启动综合征"的理解.
主要方法:
- 一个32岁的患者的案例挑战演示,该患者住院时患有胃肠道症状.
- 讨论与PrEP使用相关的临床管理场景.
- 审查与启动口服PrEP相关的常见投诉.
主要成果:
- 胃肠道乱是口服PrEP启动的一个已知的副作用.
- 准备"启动综合征"可以模仿或掩盖其他医疗条件.
- 对于接受PrEP的患者来说,全面的性健康史至关重要.
结论:
- 临床医生必须了解PrEP"启动综合征",以确保准确的诊断.
- 了解常见的PrEP副作用可以改善差异诊断和患者护理.
- 有效管理与PrEP相关的胃肠道症状对于坚持和预防至关重要.
关键词:
艾滋病病毒 艾滋病病毒 艾滋病病毒这就是为什么PrEP是PrEP.这就是STI STI.暴露前的预防 暴露前的预防性健康性健康性健康性健康性健康性传播感染性传播感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性这是副作用的副作用.相关概念视频
Gastritis III: Clinical Manifestations and Management
240
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
240
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
200
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
200
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
162
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
162
Lower GI Series: Barium Enema
267
A Barium Enema, or a lower GI series, is a specialized radiographic examination designed to visualize the lower gastrointestinal tract, specifically the colon and rectum. This procedure is instrumental in diagnosing various conditions such as colorectal cancer, polyps, diverticulosis, and inflammatory bowel disease.
Procedure Details
The examination begins by inserting a lubricated rectal tube into the patient's rectum to administer a radiopaque barium solution. The barium flow is carefully...
Procedure Details
The examination begins by inserting a lubricated rectal tube into the patient's rectum to administer a radiopaque barium solution. The barium flow is carefully...
267
Esophageal Varices-II: Clinical Features and Management
66
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
66
Endoscopic Procedures I: Esophagogastroduodenoscopy
114
An Esophagogastroduodenoscopy (EGD) is a diagnostic procedure in which an endoscopist uses a flexible, lighted endoscope to visualize the upper gastrointestinal (GI) tract. The procedure includes visualizing the oropharynx, esophagus, stomach, and the first part of the small intestine, the duodenum.
During an EGD, the endoscope can be used to:
During an EGD, the endoscope can be used to:
114


